Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rheumowin forte is a traditional herbal formulation developed and marketed by SKM Siddha and Ayurveda Company (India) Private Limited. It is an exclusive blend of nine natural herbs, including Ashwagandha, Bala (Sida cordifolia), Nirgundi (Vitex negundo), Kshudra Agnimantha (Clerodendrum inerme), Siddeswara (Delonix elata), Kalamegha (Andrographis paniculata), and Kungilia parpam (a classical Siddha medicine). The product is indicated for the management of rheumatic and musculoskeletal conditions, providing relief from joint disorders, back pain, knee pain, and various inflammatory joint conditions. It works by protecting the synovial membrane from inflammation, reducing joint pain and swelling, improving mobility and joint flexibility, and enhancing synovial fluid production. Marketed as a 100% natural product, it possesses anti-inflammatory and analgesic properties and is available as 550mg tablets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rheumowin forte.